Company
Triveni
Breaking Efficacy Ceilings
Also known as Triveni Bio, Triveni Bio, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Triveni Bio, Inc.
- triveni.bio (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Triveni Bio is a clinical-stage biotech company taking a genetics-informed approach and leveraging advanced antibody engineering to build first-in-class therapeutics that will redefine treatment paradigms for immune and inflammatory diseases.
Funding snapshot
- Total raised
- $180MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Series C, $65M2026-06-17
Funding rounds
- Series C
- $65M2026-06-17, Company stated
- Series B
- $115M2024-10-02, Company stated
Loading relationship preview